Back
Akari Therapeutics Plc Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
11
AKTX
Akari Therapeutics Plc
Last Price:
$0.34
Seasonality Move:
-24.17%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight buying pressure.
Akari Therapeutics Plc Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.41 | Sell |
| 20-day SMA: | 0.49 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.01 | Sell |
| 8-day EMA: | 0.4 | Sell |
| 20-day EMA: | 0.49 | Sell |
| 50-day EMA: | 0.64 | Sell |
| 200-day EMA: | 1.06 | Sell |
Akari Therapeutics Plc Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 27.2 | Sell |
| Chaikin Money Flow: | -45275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.41 - 0.67) | Sell |
| Bollinger Bands (100): | (0.62 - 1.04) | Sell |
Akari Therapeutics Plc Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics Plc Stock
Is Akari Therapeutics Plc Stock a Buy?
-
Akari Therapeutics Plc share price is 0.34 while AKTX 8-day simple moving average is 0.41, which is a Sell signal.
-
The stock price of AKTX is 0.34 while Akari Therapeutics Plc 20-day SMA is 0.49, which makes it a Sell.
-
Akari Therapeutics Plc 50-day simple moving average is 0.72 while AKTX share price is 0.34, making it a Sell technically.
-
AKTX stock price is 0.34 and Akari Therapeutics Plc 200-day simple moving average is 1.01, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
11
Akari Therapeutics Plc (AKTX)
is a Sell
Is Akari Therapeutics Plc a Buy or a Sell?
-
Akari Therapeutics Plc stock is rated a SellThe current Akari Therapeutics Plc [AKTX] share price is $0.34. The Score for AKTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics Plc Stock Info
Market Cap:
12.2M
Price in USD:
0.34
Share Volume:
509.6K
Akari Therapeutics Plc 52-Week Range
52-Week High:
1.73
52-Week Low:
0.29
Sell
11
Akari Therapeutics Plc (AKTX)
is a Sell
Akari Therapeutics Plc Share Price Forecast
-
What is the Akari Therapeutics Plc stock price today?The Akari Therapeutics Plc stock price is 0.34 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics Plc> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics Plc overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics Plc is overvalued.
Is Akari Therapeutics Plc Stock a Buy?
-
Akari Therapeutics Plc share price is 0.34 while AKTX 8-day exponential moving average is 0.40, which is a Sell signal.
-
The stock price of AKTX is 0.34 while Akari Therapeutics Plc 20-day EMA is 0.49, which makes it a Sell.
-
Akari Therapeutics Plc 50-day exponential moving average is 0.64 while AKTX share price is 0.34, making it a Sell technically.
-
AKTX stock price is 0.34 and Akari Therapeutics Plc 200-day simple moving average is 1.06, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics Plc
Is Akari Therapeutics Plc a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.07 per share, and an increase next year of $0.03 per share.
Technical Analysis of Akari Therapeutics Plc
Should I short Akari Therapeutics Plc stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Akari Therapeutics Plc is a Sell
-
Akari Therapeutics Plc Relative Strength Index (RSI) is 27.2, which suggest Akari Therapeutics Plc is oversold
-
The Bollinger Bands (25) for Akari Therapeutics Plc is (0.41 - 0.67), which suggest Akari Therapeutics Plc is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics Plc is (0.62 - 1.04), which suggest Akari Therapeutics Plc is a Sell
* Akari Therapeutics Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.